BR0200495A - Agentes anti-hiv - Google Patents

Agentes anti-hiv

Info

Publication number
BR0200495A
BR0200495A BR0200495-0A BR0200495A BR0200495A BR 0200495 A BR0200495 A BR 0200495A BR 0200495 A BR0200495 A BR 0200495A BR 0200495 A BR0200495 A BR 0200495A
Authority
BR
Brazil
Prior art keywords
hiv agents
agents
binding molecules
hiv
analogs
Prior art date
Application number
BR0200495-0A
Other languages
English (en)
Inventor
Manabu Wada
Naoko Wada
Original Assignee
Japan Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Chem Res filed Critical Japan Chem Res
Publication of BR0200495A publication Critical patent/BR0200495A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"AGENTES ANTI-HIV". São revelados agentes anti-HIV. Os agentes compreendem como o componente ativo uma das moléculas ligantes que ligam a CD87. Exemplos de semelhantes moléculas ligantes incluem o ativador de plasminogênio do tipo uroquinase de alto peso molecular, seu fragmento de terminal amino, seus análogos e anticorpos anti-CD87.
BR0200495-0A 2001-02-20 2002-02-20 Agentes anti-hiv BR0200495A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001042655 2001-02-20
JP2001184284A JP4034530B2 (ja) 2001-02-20 2001-06-19 抗ｈｉｖ剤

Publications (1)

Publication Number Publication Date
BR0200495A true BR0200495A (pt) 2002-12-31

Family

ID=26609669

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0200495-0A BR0200495A (pt) 2001-02-20 2002-02-20 Agentes anti-hiv

Country Status (8)

Country Link
US (3) US20020193304A1 (pt)
EP (1) EP1232755B1 (pt)
JP (1) JP4034530B2 (pt)
KR (1) KR100858862B1 (pt)
CN (1) CN100479857C (pt)
AU (1) AU784414B2 (pt)
BR (1) BR0200495A (pt)
DE (1) DE60221724T2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540529C (en) * 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
CN101094651B (zh) * 2004-12-30 2011-03-09 多贝尔有限公司 含有胶原凝集素家族蛋白质或者其变体的喷雾干燥的组合物和其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248715B1 (en) * 1993-06-01 2001-06-19 Chiron Corporation Method of treating a urokinase-type plasminogen activator-mediated disorder
US5532132A (en) * 1993-09-28 1996-07-02 President And Fellows Of Harvard University Method for regulating formation of a complex of plasminogen activator, its receptor and inhibitor
WO1996013160A1 (en) * 1994-11-01 1996-05-09 New England Deaconess Hospital Use of urokinase-type plasminogen activators to inhibit hiv infectivity
US5874254A (en) * 1996-03-29 1999-02-23 Director-General Of Agency Of Industrial Science And Technology FGF-5 analogous protein, and pharmaceutical composition containing the same
JP2001523103A (ja) * 1997-04-28 2001-11-20 ローヌ−プーラン・ロレ・エス・アー 腫瘍治療用血管形成アンタゴニストのアデノウイルスによる腫瘍内送達
WO2002009753A1 (en) * 2000-08-02 2002-02-07 H:S Hvidovre Hospital Composition and method for the treatment or prevention of hiv infection

Also Published As

Publication number Publication date
EP1232755B1 (en) 2007-08-15
AU1558902A (en) 2002-08-22
AU784414B2 (en) 2006-03-30
DE60221724D1 (de) 2007-09-27
EP1232755A3 (en) 2002-09-18
CN100479857C (zh) 2009-04-22
CN1371747A (zh) 2002-10-02
JP4034530B2 (ja) 2008-01-16
US20070190077A1 (en) 2007-08-16
KR100858862B1 (ko) 2008-09-17
US20020193304A1 (en) 2002-12-19
JP2002356442A (ja) 2002-12-13
EP1232755A2 (en) 2002-08-21
US20100135989A1 (en) 2010-06-03
DE60221724T2 (de) 2008-06-05
KR20020068299A (ko) 2002-08-27

Similar Documents

Publication Publication Date Title
EA200001041A1 (ru) Антитела к cd23, их производные и их терапевтическое применение
PT1003560E (pt) Radioprotector para peptidos marcados com radioisotopos
AR038568A1 (es) Anticuerpos anti-a beta y su uso
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BR0214650A (pt) Imunocitoquinas com seletividade modulada
EA200701386A1 (ru) Полиалкиленгликоль с остатком для конъюгации биологически активного соединения
BR0108678A (pt) Novos compostos
ATE427948T1 (de) Folat-mimetika und deren folatrezeptorbindende konjugate
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
BR0309868A (pt) Conjugados de derivados de caliqueamicina - veìculo
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
AR072596A1 (es) Un complejo proteico que comprende una proteina dimerica y un polimero no peptidico
BRPI0606934A2 (pt) Conjugado de proteína biologicamente ativa, composição, molécula de dna quimérica, vetor, célula, e, métodos para preparar conjugado de proteína biologicamente ativa, e para determinar se um dado conjugado de proteína exibe uma meia-vida de plasma modificada comparada com a meia-vida intrínseca do polipeptídeo biologicamente ativo não conjungado
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
BR0110573A (pt) Composto, composição farmacêutica que compreende esse composto, processo para a preparação de uma composição farmacêutica, utilização do composto e processo para o tratamento profilático ou terapêutico e para a preparação do composto
AR051765A1 (es) Compuestos de moleculas conjugadas con una actividad reforzada de absorcion de celulas
DK1157037T3 (da) GCSF-konjugater
BR9801652A (pt) Resorcinil-triazinas
EA200400737A1 (ru) Препарат аминокислот и рибофлавина, применимый для уменьшения токсического действия цитотоксической химиотерапии
AR047729A1 (es) Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe)
BR0000654A (pt) Preparação de composição de borracha vulcanizada com peróxido e artigos tendo ela pelo menos como um dos seus componentes
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008.